Ready-to-use formulation for Vincristine Sulfate Liposome Injection
US11559486B2 · kind B2 · utility
0Cited by
76References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2016 |
| Grant date | Jan 24, 2023 |
| Priority date | — |
| Expiry date | Jul 22, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are various compositions comprising neoplastic formulations and their methods of use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.